Q2 2013 Holdings
Filed 2013-08-14 | 22 holdings | $10.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $10.2M | 182,300 | 97.7% |
| PDL Biopharma Inc | NOTE 2.875% 2/15/15 | 69329YAE4 | $43.6K | $30,974,000 | 0.4% |
| Mannkind Corp | NOTE 3.750% 12/15/13 | 56400PAA0 | $33.6K | $34,144,000 | 0.3% |
| Opko Health Inc | NOTE 3.0% 2/1/33 | 68375NAA1 | $30.8K | $29,500,000 | 0.3% |
| Pacira Pharmaceuticals Inc | NOTE 3.25% 2/1/19 | 695127AA8 | $25.8K | $18,500,000 | 0.2% |
| Salix Pharmaceuticals Inc | COM | 795435106 | $19.8K | 300,000 | 0.2% |
| Dendreon Corp | NOTE 2.875% 1/15/16 | 24823QAC1 | $19.1K | $26,515,000 | 0.2% |
| Intermune Inc | NOTE 2.50% 9/15/18 | 45884XAE3 | $14.1K | $17,000,000 | 0.1% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $10.5K | 911,053 | 0.1% |
| Depomed Inc | COM | 249908104 | $10.4K | 1,842,280 | 0.1% |
| Oncogenex Pharmaceuticals Inc | COM | 68230A106 | $9.1K | 933,100 | 0.1% |
| Mannkind Corp | COM | 56400P201 | $7.7K | 1,184,784 | 0.1% |
| Endocyte Inc | COM | 29269A102 | $6.1K | 465,763 | 0.1% |
| Savient Pharmaceuticals Inc | NOTE 4.750% 2/1/18 | 80517QAA8 | $4.6K | $30,476,000 | 0.0% |
| Corsicanto LTD | NOTE 3.50% 1/15/32 | 220480AC1 | $2.7K | $2,500,000 | 0.0% |
| Navidea Biopharmaceuticals Inc | COM | 63937X103 | $2.3K | 868,079 | 0.0% |
| Rockwell Medical Inc | COM | 774374102 | $1.6K | 448,146 | 0.0% |
| Supernus Pharmaceuticals Inc | NOTE 7.5% 5/1/19 | 868459AA6 | $1.3K | $10,000,000 | 0.0% |
| Dendreon Corp | COM | 24823Q107 | $328 | 79,600 | 0.0% |
| Cyclacel Pharmaceuticals Inc | COM | 23254L306 | $218 | 73,895 | 0.0% |
| Ambit Biosciences Corp | COM | 02318X100 | $0 | 46 | 0.0% |